Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue-Hwa Lin

Showing results (81-90 of 146) with videos related to

Pageof 15
Sort By:
Molecular Cancer Research : MCR|September 6, 2014
RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survivalGuoyu Yu, Yu-Chen Lee, Chien-Jui Cheng, et al.
Molecular & Cellular Proteomics : MCP|December 21, 2014
Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironmentYu-Chen Lee, Martina Srajer Gajdosik, Djuro Josic, et al.
Journal of Drug Targeting|February 23, 2026
Alendronate-conjugated liposome for targeting of osteoblastic prostate cancer: Evaluation of binding to bone matrix and in vivo targeting in a mouse modelKitz Paul D Marco, Jossana A Damasco, Guoyu Yu, et al.
Cancer|June 24, 2006
Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinomaNizar Tannir, Eric Jonasch, Lance C Pagliaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapyShi-Ming Tu, Jeri Kim, Lance C Pagliaro, et al.
The Prostate|June 18, 2011
Aberrant expression of katanin p60 in prostate cancer bone metastasisXiangcang Ye, Yu-Chen Lee, Michel Choueiri, et al.
Cancer Research|May 6, 2004
Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesisDillon Phan, Chien-Jui Cheng, Matthew Galfione, et al.
The Journal of Biological Chemistry|February 13, 2013
Metabolic regulation of CaMKII protein and caspases in Xenopus laevis egg extractsFrancis McCoy, Rashid Darbandi, Si-Ing Chen, et al.
Cancer|October 6, 2018
Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapyPierre Saintigny, Yoshitsugu Mitani, Kristen B Pytynia, et al.
Cancer Research|June 15, 2011
BMP4 promotes prostate tumor growth in bone through osteogenesisYu-Chen Lee, Chien-Jui Cheng, Mehmet A Bilen, et al.
Pageof 15

Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Molecular Cancer Research : MCR|September 6, 2014
RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survivalGuoyu Yu, Yu-Chen Lee, Chien-Jui Cheng, et al.
Molecular & Cellular Proteomics : MCP|December 21, 2014
Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironmentYu-Chen Lee, Martina Srajer Gajdosik, Djuro Josic, et al.
Journal of Drug Targeting|February 23, 2026
Alendronate-conjugated liposome for targeting of osteoblastic prostate cancer: Evaluation of binding to bone matrix and in vivo targeting in a mouse modelKitz Paul D Marco, Jossana A Damasco, Guoyu Yu, et al.
Cancer|June 24, 2006
Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinomaNizar Tannir, Eric Jonasch, Lance C Pagliaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapyShi-Ming Tu, Jeri Kim, Lance C Pagliaro, et al.
The Prostate|June 18, 2011
Aberrant expression of katanin p60 in prostate cancer bone metastasisXiangcang Ye, Yu-Chen Lee, Michel Choueiri, et al.
Cancer Research|May 6, 2004
Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesisDillon Phan, Chien-Jui Cheng, Matthew Galfione, et al.
The Journal of Biological Chemistry|February 13, 2013
Metabolic regulation of CaMKII protein and caspases in Xenopus laevis egg extractsFrancis McCoy, Rashid Darbandi, Si-Ing Chen, et al.
Cancer|October 6, 2018
Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapyPierre Saintigny, Yoshitsugu Mitani, Kristen B Pytynia, et al.
Cancer Research|June 15, 2011
BMP4 promotes prostate tumor growth in bone through osteogenesisYu-Chen Lee, Chien-Jui Cheng, Mehmet A Bilen, et al.
Pageof 15